Atlas Trials

Effect of QVA149 on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Clinical trial NCT01294787 · COMPLETED

Trial details

NCT number
NCT01294787
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
COPD
Start date
2011-02-01
Primary completion
2011-11-01
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.